Organigram Global (OGI) Shares Outstanding (2018 - 2026)
Organigram Global (OGI) posted quarterly Shares Outstanding (Entity) of $134.5 million for Q3 2025, up 23.83% year-over-year from $108.6 million in Q3 2024, and up 6.58% quarter-over-quarter from $126.2 million in Q4 2024.
Organigram Global (OGI) Shares Outstanding (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Shares Outstanding (Entity) for 8 consecutive years, with $134.5 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Shares Outstanding (Entity) rose 23.83% year-over-year to $134.5 million; the TTM figure through Sep 2025 stood at $134.5 million (up 23.83% YoY), while the FY2025 annual figure was $134.5 million, up 23.83% from the prior year.
- Shares Outstanding (Entity) grew to $134.5 million in Q3 2025 per OGI's latest filing, from $126.2 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $736.9 million in Q2 2021 and bottomed at $74.7 million in Q3 2021.
- Historically, Shares Outstanding (Entity) has averaged $250.5 million across 5 years, with a median of $126.2 million in 2024.
- On a YoY basis, Shares Outstanding (Entity) climbed as much as 1474.48% in 2021 and fell as far as 51.24% in 2021.
- Organigram Global's Shares Outstanding (Entity) stood at $306.7 million in 2021, then sank by 74.42% to $78.5 million in 2022, then climbed by 3.45% to $81.2 million in 2023, then soared by 55.44% to $126.2 million in 2024, then advanced by 6.58% to $134.5 million in 2025.
- Business Quant data shows OGI's Shares Outstanding (Entity) at $134.5 million in Q3 2025, $126.2 million in Q4 2024, and $108.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 832.44 Mn |
| 10 | Organigram Global | 150.66 Mn | 150.54 Mn | 28.97 Mn | 127.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127.67 Mn |
| Dec 31, 2025 | 127.67 Mn |
| Sep 30, 2025 | 127.67 Mn |
| Mar 31, 2025 | 95.29 Mn |
| Dec 31, 2024 | 95.29 Mn |
| Sep 30, 2024 | 95.29 Mn |
| Sep 30, 2023 | 81.29 Mn |
| Aug 31, 2022 | 77.23 Mn |
| Nov 30, 2021 | 306.70 Mn |
| Aug 31, 2021 | 64.03 Mn |
| May 31, 2021 | 736.87 Mn |
| Feb 28, 2021 | 606.98 Mn |
| Nov 30, 2020 | 50.50 Mn |
| Aug 31, 2020 | 43.17 Mn |
| May 31, 2020 | 43.84 Mn |
| Feb 29, 2020 | 1.24 Bn |
| Nov 25, 2019 | 35.23 Mn |
| Aug 31, 2019 | 35.23 Mn |
| May 31, 2019 | 37.44 Mn |
| Feb 28, 2019 | 86.25 Mn |